Please login to the form below

Not currently logged in
Email:
Password:

AVEO's financial head joins ImmunoGen

David Johnston appointed chief financial officer
David Johnston, Immunogen

David Johnston has left his role as chief financial officer of AVEO Pharmaceuticals to join ImmunoGen in the same role.

Johnston's switch comes after more than six years at AVEO having joined the company from his role as senior VP of finance corporate planning and analysis at Genzyme.

Other previous roles include VP finance and chief financial officer of Genzyme Biosurgery.

In his new role, Johnston will head the financial operations of one of the leading biotechs working to develop antibody-drug conjugates in cancer, with ImmunoGen's successes including the breast cancer treatment Kadcyla (trastuzumab emtansin) it developed in partnership with Roche.

“I am delighted to have Dave join ImmunoGen,” commented ImmunoGen's CEO Daniel Junius.

“His depth of experience in both senior financial positions and in corporate planning makes Dave well-suited to help successfully advance the company to our next stages,” added Junius.

7th January 2014

From: Research, Sales

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics